0641 Effects of Weight Loss During Long-Term Solriamfetol Treatment on Cardiometabolic Indices

Abstract Introduction Increased prevalence of obesity has been reported in patients with narcolepsy and obstructive sleep apnea (OSA). Results from a 1-year open-label extension (OLE) study showed ≥5% weight loss in 4.5%, 17.3%, and 32.4% of participants with narcolepsy or OSA receiving solriamfetol...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Sleep (New York, N.Y.) N.Y.), 2020-05, Vol.43 (Supplement_1), p.A245-A245
Hauptverfasser:	Malhotra, A, Strollo, P, Pepin, J, Schweitzer, P, Lammers, G, Hedner, J, Redline, S, Chen, D, Chandler, P, Bujanover, S, Menno, D, Strohl, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Glucose Sleep apnea Sleep disorders Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!